Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

GlaxoSmithKline Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (243)
ARTG (107)
Australian public assessment report (AusPar) (41)
Prescription medicine registration (20)
Designation or determination (5)
Prescription medicine evaluation (4)
Prescription medicine decision summary (3)
Face mask cancellation (1)

Date

2025 (25)
2024 (13)
2023 (18)
2022 (61)
2021 (12)
2020 (59)
2019 (30)
2018 (27)
2017 (24)
2016 (11)
2015 (49)
2014 (21)
2013 (9)
2012 (6)
2011 (4)
2010 (7)
2009 (3)
2008 (6)
2007 (5)
2006 (3)
2005 (4)
2004 (1)
2003 (3)
2002 (1)
2001 (1)
2000 (3)
1999 (1)
1998 (5)
1997 (4)
1995 (1)
1991 (6)

Search

Sponsor content

424 result(s) found, displaying 421 to 424

VENTOLIN NEBULES salbutamol 2.5mg/2.5mL (as sulfate) inhalation solution ampoule (12533)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN NEBULES salbutamol 2.5mg/2.5mL (as sulfate) inhalation solution ampoule.
VENTOLIN OBSTETRIC salbutamol 5mg/5mL (as sulfate) injection ampoule (12528)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN OBSTETRIC salbutamol 5mg/5mL (as sulfate) injection ampoule.
VENTOLIN NEBULES salbutamol 5mg/2.5mL (as sulfate) inhalation solution ampoule (12534)

13 August 1991

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VENTOLIN NEBULES salbutamol 5mg/2.5mL (as sulfate) inhalation solution ampoule.
Mask, <specify> (GlaxoSmithKline Australia Pty Ltd)

Face mask cancellation

Sponsor-initiated cancellation

Pages

First page
Previous page
…
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Current page 43

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.